Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release on the Unaudited Financial Results of the Company for the 3rd Quarter and 9 (Nine) months ended 31st December, 2021 Krishna Institute of Medical Sciences Ltd - 543308 - Approval Of Unaudited Financial Results For The 3Rd Quarter And 9 (Nine) Months Ended 31St December 2021
Approval of unaudited Financial Results for the 3rd Quarter and 9 (Nine) months ended 31st December 2021 Krishna Institute of Medical Sciences Ltd - 543308 - Board Meeting Outcome for Board Meeting Outcome
Outcome of the Board Meeting held on 10.02.2022 Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Dr. Bhaskara Rao Bollineni - Managing Director, Dr. Abhinay Bollineni - Executive Director and CEO, and Mr. Vikas Maheshwari - Chief Financial Officer, would participate in a conference call with analysts and investors, being hosted by IIFL Securities on Thursday 10th February, 2022, at 6:00 pm IST, to discuss the company's business strategy and outlook post the declaration of Q3FY22 financial results. Krishna Institute of Medical Sciences Ltd - 543308 - Board Meeting Intimation for Intimation Of Board Of Directors Meeting Of The Company
Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2022 ,inter alia, to consider and approve A meeting of the Board of Directors of the Company will be held on Thursday, 10th February, 2022 inter-alia to consider and approve, the unaudited financial results for the third quarter and 9 month's period ended 31st December, 2021. Krishna Institute of Medical Sciences Ltd - 543308 - Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Mr Umashankar ManthaDesignation :- Company Secretary and Compliance Officer Krishna Institute of Medical Sciences Ltd - 543308 - Shareholding for the Period Ended December 31, 2021
Krishna Institute of Medical Sciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here Krishna Institute of Medical Sciences Ltd - 543308 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31 December, 2021 Krishna Institute of Medical Sciences Ltd - 543308 - Closure of Trading Window
Intimation of Closure of Trading Window under the SEBI (Prohibition of Insider Trading) Regulations, 2015
India can see surge in Covid-19 cases by end of January 2022: Expert
India can see a surge in Covid-19 cases by the end of January 2022, a Hyderabad-based doctor warned."We expect a surge in COVID-19 numbers by end of January because we are no different from the world. We will face what the world is facing," Dr Sambit, Director (Medical) of Krishna Institute of Medical Sciences (KIMS), Hyderabad said."As of now we haven't seen a significant surge in the number of COVID-19 cases, but it has been tricking slowly. Over the last month, the count down was zero but since the last week, patients have been reporting, though they are not diagnosed with severe disease," Dr said."We are not sure whether it's an omicron variant or delta variant because that needs genetic testing. Most of them are suffering from fever, headache, a stuffy nose, and cough. As of now, we haven't seen any patient suffering from shortness of breath required a hospitalisation," he added.Talking about those below 18 years who haven't been vaccinated yet, Dr Sambit said, "try to avoid...